Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Frailty 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Gallbladder Neoplasms 1Breast Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Geriatric Assessment × Gastrointestinal × Clear all
NCT03894917 2026-01-08

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

The University of Texas Health Science Center at San Antonio

Recruiting
84 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06999512 2025-05-31

HPB70+

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Not yet recruiting
526 enrolled
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡